Skip to content
HowShorted

Ampio Pharmaceuticals Inc. short interest in 2019

In 2019, Ampio Pharmaceuticals Inc.'s disclosed short interest ran from 17.67% of shares outstanding on 15 Jan 2019 to 6.43% on 31 Dec 2019, a change of -11.24 percentage points. The year's high was 20.59% on 31 May 2019 and its low 6.43% on 31 Dec 2019, averaging 14.50% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 78.02 days on 31 May 2019. Full history: Ampio Pharmaceuticals Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Ampio Pharmaceuticals Inc. in 2019

2019 in figures

Start of year
17.67% (15 Jan 2019)
End of year
6.43% (31 Dec 2019)
Change
-11.24 pp
High
20.59% (31 May 2019)
Low
6.43% (31 Dec 2019)
Average
14.50%
Highest days to cover
78.02 (31 May 2019)
SEC filings marked
6

Every report in 2019

Ampio Pharmaceuticals Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201917.67%26.71
31 Jan 201918.46%42.08
15 Feb 201919.02%23.92
28 Feb 201919.56%36.25
15 Mar 201918.91%44.58
29 Mar 201919.26%49.0010-K filed
15 Apr 201919.55%53.33results (8-K)
30 Apr 201920.14%44.67results (8-K)
15 May 201920.29%63.5410-Q filed
31 May 201920.59%78.02
14 Jun 201919.91%10.14
28 Jun 201917.73%6.38
15 Jul 201914.63%20.03
31 Jul 201913.98%28.51
15 Aug 201910.94%28.3210-Q filed
30 Aug 201910.63%11.53
13 Sep 201910.80%27.45
30 Sep 201911.19%21.98
15 Oct 201911.13%38.20
31 Oct 20196.99%10.65
15 Nov 20196.66%26.8110-Q filed
29 Nov 20196.71%19.58
13 Dec 20196.71%26.92
31 Dec 20196.43%11.69

See also: Ampio Pharmaceuticals Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.